Thorne HealthTech (THRN) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Dr. Gary A. Thorne
Lisa D. Thorne
Dr. Doris K. Thorne
Short Interest in Thorne HealthTech, Inc. (NASDAQ:THRN) Decreases By 19.7%
Thorne HealthTech, Inc. (NASDAQ:THRN - Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 145,500 shares, a decrease of 19.7% from the August 31st total of 181,100 shares. Currently, 1.2% of the company's shares are short sold. Based on an average daily volume of 215,800 shares, the short-interest ratio is currently 0.7 days.
Royce & Associates LP Invests $620,000 in Thorne HealthTech, Inc. (NASDAQ:THRN)
Royce & Associates LP acquired a new position in Thorne HealthTech, Inc. (NASDAQ:THRN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 134,300 shares of the company's stock, valued at approximately $620
Thorne HealthTech Inc
TWOU, OTLY and LWAY among mid-day movers
Canaccord Genuity Group Boosts Thorne HealthTech (NASDAQ:THRN) Price Target to $7.00
Canaccord Genuity Group raised their price objective on shares of Thorne HealthTech from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Friday.
Update: THRN and FREE, August 9
Thorne HealthTech Reports Second Quarter 2023 Results
Thorne HealthTech's Earnings Outlook
134,300 Shares in Thorne HealthTech, Inc. (NASDAQ:THRN) Purchased by Royce & Associates LP
Royce & Associates LP purchased a new position in shares of Thorne HealthTech, Inc. (NASDAQ:THRN - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 134,300 shares of the company's stock, valued at
Thorne Healthtech Shares Rise 10% on Sale Report
Update: THRN, July 21
Thorne HealthTech (NASDAQ: THRN)
3 Penny Stocks Set to Pass the $5 Mark Soon
Thorne Healthtech Inc.
Thorne HealthTech (NASDAQ:THRN) Updates FY 2023 Earnings Guidance
Thorne HealthTech (NASDAQ:THRN) updated its FY 2023 earnings guidance. The company provided EPS guidance of $0.25-$0.31 for the period, compared to the consensus estimate of $0.31. The company also issued revenue guidance of $280.00 millionillion-$290.00 millionillion, compared to the consensus estimate of $283.21 millionillion.
Thorne HealthTech (THRN) Gets a Buy from RBC Capital
Update: THRN and RLGT, May 12
Get Thorne HealthTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRN and its competitors with MarketBeat's FREE daily newsletter.

Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

THRN Media Mentions By Week

THRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

THRN
News Sentiment

-0.34

0.36

Average
Consumer Defensive
News Sentiment

THRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

THRN Articles
This Week

0

1

THRN Articles
Average Week

Get Thorne HealthTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:THRN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners